Ishioka S, Hiyama K, Nishisaka T, Yokozaki M, Maeda H, Maeda A, Jougasaki Y, Yamakido M
Second Department of Internal Medicine, School of Medicine, Hiroshima University.
Intern Med. 2000 May;39(5):404-6. doi: 10.2169/internalmedicine.39.404.
The prognosis of diffuse panbronchiolitis (DPB) has been remarkably improved after the development of low-dose erythromycin therapy, possibly due to anti-inflammatory rather than anti-infective mechanisms. Interestingly, DPB associated with lung cancer is quite rare. Here, we report an autopsy case of DPB who developed lung cancer after a long successful therapy with low-dose erythromycin.
在低剂量红霉素疗法出现后，弥漫性泛细支气管炎（DPB）的预后有了显著改善，这可能是由于抗炎机制而非抗感染机制。有趣的是，与肺癌相关的DPB非常罕见。在此，我们报告一例DPB尸检病例，该患者在长期成功接受低剂量红霉素治疗后发生了肺癌。
